Work

723: Comparative Effectiveness and Safety of Vedolizumab Vs. Tumor Necrosis Factor Antagonists in Older Adults With Ibd: a Nationwide Cohort Study

Year: 2022

Type: article

Source: Gastroenterology

DOI: 10.1016/s0016-5085(22)60442-6

Authors: Siddharth Singh, Aske Iversen, Kristine H. Allin, Tine Jess

Language: English

Topic: Inflammatory Bowel Disease

Subfield: Genetics

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4283022374

FWCI:

Cites:

Cited by:

Related to: 10